EcoDrugPlus


Trade Names	CHOLESTYRAMINE CHOLESTYRAMINE LIGHT CHOLYBAR LOCHOLEST LOCHOLEST LIGHT PREVALITE QUESTRAN QUESTRAN LIGHT
Synonyms	A-3384 A3384 Cholestyramine Cholestyramine light Cholestyramine resin Cholybar Colestyramine Colestyramine 20 Cuemid Duolite ap143 resin Locholest Locholest light Prevalite Questran Questran light
Status
Molecule Category	UNKNOWN
UNII	4B33BGI082

Trade Names

CHOLESTYRAMINE

CHOLESTYRAMINE LIGHT

CHOLYBAR

LOCHOLEST

LOCHOLEST LIGHT

PREVALITE

QUESTRAN

QUESTRAN LIGHT

Synonyms

A-3384

A3384

Cholestyramine

Cholestyramine light

Cholestyramine resin

Cholybar

Colestyramine

Colestyramine 20

Cuemid

Duolite ap143 resin

Locholest

Locholest light

Prevalite

Questran

Questran light

Status

Molecule Category

UNKNOWN

UNII

4B33BGI082


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Mechanism of Action	Action	Reference
Bile acids sequestering agent	SEQUESTERING AGENT	DailyMed

Mechanism of Action

Action

Reference

Bile acids sequestering agent

SEQUESTERING AGENT

DailyMed

Resources	Reference
ChEMBL	CHEMBL1201625
FDA SRS	4B33BGI082
PubChem	70695641

Resources

Reference

ChEMBL

CHEMBL1201625

FDA SRS

4B33BGI082

PubChem

70695641


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

CHOLESTYRAMINE

Bioactivity

Cross References